TWEAK signals through JAK-STAT to induce tumor cell apoptosis

Cytokine

Volumn 61, Issue 1, 2013, Pages 210-217

  Chapman, Mark S ^a   Wu, Lan ^a   Amatucci, Aldo ^a   Ho, Steffan N ^a   Michaelson, Jennifer S ^a  

^a BIOGEN   (United States)

Author keywords

Fn 14; Interferon ; Interferon ; JAK STAT; TWEAK

Indexed keywords

ANTIBODY P4A8; CASPASE 3; CASPASE 7; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; JANUS KINASE; JANUS KINASE 2 INHIBITOR; JANUS KINASE INHIBITOR; RECEPTOR ANTIBODY; STAT1 PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR; TWEAK RECEPTOR FN14; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG MECHANISM; DRUG SENSITIVITY; HUMAN; HUMAN CELL; MOUSE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; INTERFERON-ALPHA; INTERFERON-BETA; INTERFERON-GAMMA; JANUS KINASES; MICE; PHOSPHORYLATION; PROTEIN BINDING; RECEPTORS, CELL SURFACE; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR;

MUS;

EID: 84869871676     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.09.020     Document Type: Article

References (27)

1. Brown S.A., Richards C.M., et al. The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation. Biochem J 2003, 371(Pt 2):395-403.
2. Browning J.L., Miatkowski K., et al. Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines. J Exp Med 1996, 183(3):867-878.
3. Chicheportiche Y., Bourdon P.R., et al. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 1997, 272(51):32401-32410.
4. Culp P.A., Choi D., et al. Antibodies to TWEAK receptor inhibit human tumor growth through dual mechanisms. Clin Cancer Res: An Offic J Am Assoc Cancer Res 2010, 16(2):497-508.
5. Gough D.J., Levy D.E., et al. IFNgamma signaling-does it mean JAK-STAT?. Cytokine Growth Factor Rev 2008, 19(5-6):383-394.
6. Han S., Yoon K., et al. TNF-related weak inducer of apoptosis receptor, a TNF receptor superfamily member, activates NF-kappa B through TNF receptor-associated factors. Biochem Biophys Res Commun 2003, 305(4):789-796.
7. Hanissian S.H., Geha R.S. Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells. Immunity 1997, 6(4):379-387.
8. Justo P., Sanz A.B., et al. Cytokine cooperation in renal tubular cell injury: the role of TWEAK. Kidney Int 2006, 70(10):1750-1758.
9. Meighan-Mantha R.L., Hsu D.K., et al. The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration. J Biol Chem 1999, 274(46):33166-33176.
10. Michaeslon J.S., Kelly R., et al. The anti-Fn14 antibody BIIB036 inhibits tumor growth in xenografts and patient derived primary tumor models and enhances efficacy of chemotherapeutic agents in multiple xenograft models. Cancer Biol Ther 2012, 13(9):812-821.
11. Michaelson J.S., Amatucci A., et al. Development of an Fn14 agonistic antibody as an anti-tumor agent. mAbs 2011, 3(4):362-375.
12. Michaelson J.S., Burkly L.C. Therapeutic targeting of TWEAK/Fnl4 in cancer: exploiting the intrinsic tumor cell killing capacity of the pathway. Results Problems Cell Differ 2009, 49:145-160.
13. Michaelson J.S., Cho S., et al. Tweak induces mammary epithelial branching morphogenesis. Oncogene 2005, 24(16):2613-2624.
14. Nakayama M., Ishidoh K., et al. Multiple pathways of TWEAK-induced cell death. J Immunol 2002, 168(2):734-743.
15. Ossina N.K., Cannas A., et al. Interferon-gamma modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J Biol Chem 1997, 272(26):16351-16357.
16. Raitano A.B., Korc M. Tumor necrosis factor up-regulates gamma-interferon binding in a human carcinoma cell line. J Biol Chem 1990, 265(18):10466-10472.
17. Schindler C., Levy D.E., et al. JAK-STAT signaling: from interferons to cytokines. J Biol Chem 2007, 282(28):20059-20063.
18. Schmitz F., Heit A., et al. Interferon-regulatory-factor 1 controls toll-like receptor 9-mediated IFN-beta production in myeloid dendritic cells. Eur J Immunol 2007, 37(2):315-327.
19. Schroder K., Hertzog P.J., et al. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukocyte Biol 2004, 75(2):163-189.
20. Suk K., Chang I., et al. Interferon gamma (IFNgamma) and tumor necrosis factor alpha synergism in ME-180 cervical cancer cell apoptosis and necrosis. IFNgamma inhibits cytoprotective NF-kappa B through STAT1/IRF-1 pathways. J Biol Chem 2001, 276(16):13153-13159.
21. Vince J.E., Chau D., et al. TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha. J Cell Biol 2008, 182(1):171-184.
22. Wiley S.R., Cassiano L., et al. A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity 2001, 15(5):837-846.
23. Wilson C.A., Browning J.L. Death of HT29 adenocarcinoma cells induced by TNF family receptor activation is caspase-independent and displays features of both apoptosis and necrosis. Cell Death Differ 2002, 9(12):1321-1333.
24. Wingett D.G., Vestal R.E., et al. CD40 is functionally expressed on human breast carcinomas: variable inducibility by cytokines and enhancement of Fas-mediated apoptosis. Breast Cancer Res Treat 1998, 50(1):27-36.
25. Yarilina A., Ivashkiv L.B. Type I interferon: a new player in TNF signaling. Current Directions in Autoimmun 2010, 11:94-104.
26. Yarilina A., Park-Min K.H., et al. TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes. Nat Immunol 2008, 9(4):378-387.
27. Yonehara S., Ishii A., et al. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989, 169(5):1747-1756.